The aftercare of the patient with the neuroleptic malignant syndrome.
The neuroleptic malignant syndrome (NMS) is an idiosyncratic reaction to neuroleptic drugs, made up of hyperthermia, muscular rigidity, disturbance of level of consciousness and autonomic dysfunction. It is potentially lethal and should be kept in mind whilst using anti-psychotic drugs; as most patients treated by them require further anti-psychotic treatment, the clinician faces the problem of treating those patients after a NMS episode, yet reports in the literature have generally neglected the problem of late management. A patient suffering from a psychosis and NMS is presented, and a rationale for management offered.
Aizenberg
D
D
Shalev
A
A
Munitz
H
H
D000328:Adult; D000359:Aftercare; D001480:Basal Ganglia Diseases / Q000628:therapy*; D004565:Electroconvulsive Therapy; D006801:Humans; D008297:Male; D008728:Methotrimeprazine / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000150:complications / Q000628:therapy*; D011618:Psychotic Disorders / Q000150:complications / Q000628:therapy; D013881:Thioridazine / Q000627:therapeutic use
D008728:Methotrimeprazine; D013881:Thioridazine